LUMIFY 0.025% EYE DROP
FDA nonproprietary name: brimonidine tartrate
For 1 mL
Pharmacies pay
$2.00 – $3.43 filed
1 × $1.99701 to $3.42973 per ML (the 2 NDCs differ)
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$7.30 – $8.94 estimated
NADAC for the pack + 15% + $5.00 fee per fill
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-08-19, 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LUMIFY 0.025% EYE DROP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as brimonidine tartrate, under the trade name “LUMIFY Redness Reliever Eye Drops”.
FDA gives its dosage form as solution/ drops and its route as ophthalmic.
The labeler, the company named on the label, is Bausch & Lomb Incorporated.
FDA’s Established Pharmacologic Class for it is alpha-Adrenergic Agonist.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and marks it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.00 – $3.43 for 1 mL, depending on the NDC ($1.99701 to $3.42973 per ML), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-08-19 and 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 4, carried forward from the previous file; 5, calculated based on package size.
The NADAC of 1 of these 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-08-19. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 2 NDCs
- 24208-0537-08 · Bausch & Lomb Incorporated · $3.42973 per ML · eff. 2026-08-19 filed carried forward
- 24208-0537-25 · Bausch & Lomb Incorporated · $1.99701 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
6 other products in the NADAC file share the FDA nonproprietary name brimonidine tartrate with LUMIFY 0.025% EYE DROP.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ALPHAGAN P 0.1% DROPS | $37.25406 to $37.35499 per ML filed | $37.44191 per ML filed |
| ALPHAGAN P 0.15% EYE DROPS | $39.74875 to $39.84933 per ML filed | $37.44191 per ML filed |
| BRIMONIDINE 0.2% EYE DROP | $0.50116 to $0.85299 per ML filed | $3.90369 per ML filed |
| BRIMONIDINE TARTRATE 0.1% DROP | $6.5539 to $10.51982 per ML filed | $3.90369 per ML filed |
| BRIMONIDINE TARTRATE 0.15% DRP | $9.74729 to $11.65198 per ML filed | $3.90369 per ML filed |
| LUMIFY 0.025% EYE DROP this page | $1.99701 to $3.42973 per ML filed | We don’t know yet |
| MIRVASO 0.33% GEL PUMP | $21.46607 per GM filed | $20.58117 per GM filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $1.99701 per ML filed.
Of the 14 other products in FDA’s alpha-Adrenergic Agonist class priced per ML, 9 have a higher middle NADAC price and 5 a lower one. The one in the middle is ADRENALIN 1 MG/ML VIAL, at $7.79554 per ML filed (eff. 2025-10-28).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-10-28, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
- Which NDC (the 11-digit number on the package) is this? Pharmacies pay $1.99701 to $3.42973 per ML for this product, depending on the NDC.
- It is sold over the counter, so shelf prices vary from store to store: what does it cost per unit here?
- How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 mL?
- The FDA package descriptions of this product’s NDCs give different amounts (2.5 mL, 7.5 mL). So the card starts at 1 ML; change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- MIDODRINE HCL 10 MG TABLET
- EPINEPHRINE 0.15 MG AUTO-INJCT
- BRIMONIDINE-TIMOLOL 0.2%-0.5%
- COMBIGAN 0.2%-0.5% EYE DROPS
- SIMBRINZA 1%-0.2% EYE DROP